Overview
Effects of Delta-9-THC and Iomazenil in Healthy Humans
Status:
Active, not recruiting
Active, not recruiting
Trial end date:
2021-12-01
2021-12-01
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The study aims to examine the combined effects of delta-9-tetrahydrocannabinol (∆-9-THC or THC) and iomazenil on thinking, perception, mood, memory, attention, and electrical activity of the brain (EEG). THC is the active ingredient of marijuana, cannabis, "ganja", or "pot". Iomazenil is a drug that works opposite to drugs like valium. The purpose of this study is to determine whether the administration of iomazenil will alter the effects of THC.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Yale UniversityTreatments:
Ethanol
gamma-Aminobutyric Acid
Criteria
Inclusion Criteria:- Exposed to cannabis at least once in their lifetime
Exclusion Criteria:
- Cannabis naïve
- History of hearing deficit